Julie Swain

Julie Ann Swain, M.D., is an American cardiac surgeon, the Vice Chair of Clinical Performance for the Mount Sinai Health System, and the Director of the Center for Medical Devices at Mount Sinai Heart. In addition, she serves as the Professor of Cardiovascular Surgery and the Director of Clinical Research in the Department of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai.^[1]

Personal life

Dr. Julie Swain has an identical twin sister, Dr. Judith Swain (cardiologist).^[2]

Education^[3][4]

• Bachelor of Science (BS) - UCLA - 1970
• Doctor of Medicine (MD) - Baylor College of Medicine - 1973
• Cardiovascular Medicine Postdoctoral Research Fellow - Harvard University - 1973-1974
• General Surgery Residency - Baylor College of Medicine - 1974-1979
• Cell Biophysics Postdoctoral Research Fellow - Baylor College of Medicine - 1975-1976
• Thoracic Surgery Residency - University of California San Diego - 1979-1981

Professional background^[3]

• University of California at San Diego, Assistant Professor of Surgery, 1981-1983
• Louisiana State University at Shreveport, Chief of Cardiothoracic Surgery, 1983-1986
• National Institutes of Health (NIH), NHLBI, Senior Investigator and Senior Surgeon, 1986-1990
• University of Nevada, Professor of Surgery and Chief Cardiothoracic Surgery 1990-1995
• University of Kentucky, Professor of Surgery and Chief Cardiothoracic Surgery, 1996-2000
• National Aeronautics and Space Administration (NASA), Acting Deputy Associate Administrator, 2000-2002
• US Food and Drug Administration (FDA), Special Assistant to the Director, Division of Cardiovascular Devices 2002-2013
• Icahn School of Medicine at Mount Sinai, Department of Cardiovascular Surgery, Professor and Vice Chair, Director of Research

Honors, decorations, awards, and distinctions

Dr. Swain is the first female to head a cardiac surgery department at an American medical school.^[2]

Publications^[1]

• Abraham VS, Swain JA, Forgash AJ, Williams BL, Musulin MM. Ischemic preconditioning protects against paraplegia after transient aortic occlusion in the rat. The Annals of Thoracic Surgery 2000 Feb; 69(2).
• Zhang P, Abraham VS, Kraft KR, Rabchevsky AG, Scheff SW, Swain JA. Hyperthermic preconditioning protects against spinal cord ischemic injury. The Annals of Thoracic Surgery 2000 Nov; 70(5).
• Hartz RS, Swain JA, Mickleborough L. Sixty-year perspective on coronary artery bypass grafting in women. The Journal of thoracic and cardiovascular surgery 2003 Sep; 126(3).
• Sapirstein W, Chen E, Swain J, Zuckerman B. US FDA perspective on regulatory issues affecting circulatory assist devices. Expert review of medical devices 2006 Nov; 3(6).
• Swain JA, Hartz RS. Assessing quality in cardiac surgery: why this is necessary in the twenty-first century. Perfusion 2000 Jun; 15(3).
• Swain J, Flynn E Jr, Greely W, Hallenbeck J, Liberthson R. Patent Foramen Ovale and Extravehicular Activity. Report to NASA Office of Life and Microgravity Applications 1999 November.
• Zuckerman B, Sapirstein W, Swain J. The FDA Role in the Development of Percutaneous Heart Valve Technology.. EuroIntervention Supplements 2006; 1(Supplement A): A75-A78.
• Zuckerman B, Sapirstein W, Swain J. FDA perspective on clinical trial design for cardiovascular devices. Ann Thorac Surg. 2006 September; 82(3): 773-5.
• Aguel F, Hillebrenner M, Stewart S, Swain J, Hampshire V, Zuckerman B. US Regulatory Decisions for Heart Valves Implanted with Minimally Invasive Surgery. Cardiovascular Engineering and Technology 2011; 2(2): 62-65.

References